VBIV
Income statement / Annual
Last year (2023), VBI Vaccines Inc.'s total revenue was $8.68 M,
an increase of 702.40% from the previous year.
In 2023, VBI Vaccines Inc.'s net income was -$92.84 M.
See VBI Vaccines Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
03/31/2014 |
| Operating Revenue |
$8.68 M
|
$1.08 M
|
$631,000.00
|
$1.06 M
|
$2.22 M
|
$3.36 M
|
$865,000.00
|
$548,000.00
|
$955,000.00
|
$0.00
|
| Cost of Revenue |
$14.50 M |
$11.28 M |
$10.77 M |
$9.17 M |
$7.90 M |
$4.51 M |
$5.19 M |
$3.67 M |
$3.76 M |
$0.00 |
| Gross Profit |
-$5.82 M |
-$10.19 M |
-$10.14 M |
-$8.11 M |
-$5.68 M |
-$1.15 M |
-$4.33 M |
-$3.12 M |
-$2.80 M |
$0.00 |
| Gross Profit Ratio |
-0.67 |
-9.42 |
-16.07 |
-7.64 |
-2.56 |
-0.34 |
-5 |
-5.7 |
-2.93 |
0 |
| Research and Development
Expenses |
$9.34 M
|
$15.51 M
|
$19.56 M
|
$14.86 M
|
$26.33 M
|
$38.47 M
|
$20.92 M
|
$9.97 M
|
$618,000.00
|
$0.00
|
| General & Administrative
Expenses |
$42.14 M
|
$56.12 M
|
$38.34 M
|
$20.65 M
|
$14.09 M
|
$20.79 M
|
$12.03 M
|
$11.76 M
|
$6.68 M
|
$1.42 M
|
| Selling & Marketing
Expenses |
-$1.99 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$40.15 M
|
$56.12 M
|
$38.34 M
|
$20.65 M
|
$14.09 M
|
$20.79 M
|
$12.03 M
|
$11.76 M
|
$6.68 M
|
$1.42 M
|
| Other Expenses |
$24.60 M |
$0.00 |
$0.00 |
$20.65 M |
$20.38 M |
$20.79 M |
$12.03 M |
$11.76 M |
$862,000.00 |
$3.87 M |
| Operating Expenses |
$49.50 M |
$71.63 M |
$57.89 M |
$35.51 M |
$40.42 M |
$59.25 M |
$32.95 M |
$21.73 M |
$8.16 M |
$5.29 M |
| Cost And Expenses |
$63.99 M |
$82.90 M |
$68.66 M |
$44.68 M |
$48.33 M |
$63.76 M |
$38.15 M |
$25.40 M |
$11.92 M |
$5.29 M |
| Interest Income |
$1.66 M |
$1.39 M |
$372,000.00 |
$613,000.00 |
$835,000.00 |
$622,000.00 |
$0.00 |
$0.00 |
$44,000.00 |
$551,641.00 |
| Interest Expense |
$8.06 M |
$4.01 M |
$4.73 M |
$2.71 M |
$2.20 M |
$3.25 M |
$2.88 M |
$324,000.00 |
$1.13 M |
$0.00 |
| Depreciation &
Amortization |
$1.99 M
|
$2.06 M
|
$1.84 M
|
$1.65 M
|
$1.20 M
|
$542,000.00
|
$730,000.00
|
$606,000.00
|
$1.14 M
|
$30,463.00
|
| EBITDA |
-$53.32 M
|
-$106.02 M
|
-$62.81 M
|
-$41.26 M
|
-$52.40 M
|
-$59.59 M
|
-$36.55 M
|
-$24.24 M
|
-$9.52 M
|
-$3.80 M
|
| EBITDA Ratio |
-6.14 |
-75.62 |
-107.82 |
-41.11 |
-20.76 |
-17.66 |
-42.25 |
-44.24 |
-10.26 |
0 |
| Operating Income Ratio
|
-6.37
|
-75.62
|
-107.82
|
-41.11
|
-23.59
|
-18.01
|
-43.1
|
-45.35
|
-9.25
|
0
|
| Total Other
Income/Expenses Net |
-$37.53 M
|
-$31.48 M
|
-$1.72 M
|
-$2.61 M
|
-$2.41 M
|
-$3.19 M
|
-$2.15 M
|
-$135,000.00
|
-$6.05 M
|
$553,343.00
|
| Income Before Tax |
-$92.84 M |
-$113.30 M |
-$69.75 M |
-$46.23 M |
-$54.81 M |
-$63.60 M |
-$39.43 M |
-$24.99 M |
-$14.88 M |
-$4.59 M |
| Income Before Tax Ratio
|
-10.69
|
-104.72
|
-110.54
|
-43.57
|
-24.68
|
-18.96
|
-45.58
|
-45.59
|
-15.59
|
0
|
| Income Tax Expense |
$1.82 M |
$27.65 M |
$2.90 M |
$1.06 M |
$992,000.00 |
$560,000.00 |
-$431,000.00 |
-$1.78 M |
-$129,000.00 |
-$840,314.64 |
| Net Income |
-$92.84 M |
-$140.95 M |
-$72.65 M |
-$47.29 M |
-$55.81 M |
-$63.60 M |
-$39.00 M |
-$23.21 M |
-$14.76 M |
-$4.59 M |
| Net Income Ratio |
-10.69 |
-130.27 |
-115.13 |
-44.57 |
-25.13 |
-18.96 |
-45.08 |
-42.34 |
-15.45 |
0 |
| EPS |
-5.96 |
-16.37 |
-8.55 |
-6.5 |
-14.02 |
-29.06 |
-26.49 |
-23.17 |
-35.05 |
-21.27 |
| EPS Diluted |
-5.96 |
-16.37 |
-8.55 |
-6.5 |
-14.02 |
-29.06 |
-26.49 |
-23.17 |
-35.05 |
-21.27 |
| Weighted Average Shares
Out |
$15.57 M
|
$8.61 M
|
$8.50 M
|
$7.28 M
|
$3.98 M
|
$2.19 M
|
$1.47 M
|
$1.00 M
|
$421,006.00
|
$215,977.00
|
| Weighted Average Shares
Out Diluted |
$15.57 M
|
$8.61 M
|
$8.50 M
|
$7.28 M
|
$3.98 M
|
$2.19 M
|
$1.47 M
|
$1.00 M
|
$421,006.00
|
$215,977.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
